Biography

Dr. Sarah Chen holds a PhD in Biochemistry from Stanford University with over 15 years of experience in peptide synthesis and therapeutic applications. She has led multiple FDA-approved peptide drug development programs and published 80+ peer-reviewed papers in journals including Nature, Cell, and Journal of Medicinal Chemistry. Her research focuses on GLP-1 receptor agonists and their metabolic applications.

Qualifications & Certifications

• ✅ PhD Biochemistry (Stanford)
• ✅ Board Certified Toxicologist
• ✅ GMP Qualified Person

Key Projects & Achievements

• Lead Scientist — GLP-1 Analog Development Program (2018-2023)
• Principal Investigator — Peptide-Based Obesity Therapeutics NIH Grant
• Co-author — WHO Guidelines on Peptide Therapeutics Safety

Published Research